Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

A 4-year-old boy has a rare type of hair loss in a line pattern on his scalp.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Excessive sun protection might contribute to frontal fibrosing alopecia.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

Androgenetic alopecia is complex and needs more research for better treatments.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Understanding alopecia areata's patterns can improve future research and treatments.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Hair loss treatments work better with lifestyle changes.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

A 19-year-old man had a rare skin condition on one side of his face that looked like another skin disease.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Trichoscopy effectively helps diagnose different types of hair loss in women.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The model helps understand alopecia areata and suggests ways to improve treatment by targeting immune issues.